Chemical
Browse
Active Pharmaceutical Ingredients
Bioactive chemicals
Agrochemicals
Search
Chemical Structure
Explore
Chemical Similarity
Transformation
Browse
Prodrugs
Drug Metabolites
Metabolite Datasets
Cytochrome P450
Homo sapiens »
CYP1
CYP2
CYP3
CYP4
CYP5
CYP7
CYP8
CYP11
CYP17
CYP19
CYP20
CYP21
CYP24
CYP26
CYP27
CYP39
CYP46
CYP51
Mus musculus
Danio rerio
Oncorhynchus mykiss
Comparison of CYPs
Biochemical Action
Browse
Target Level (ChEMBL)
Level 1
Level 2
Level 3
Level 4
Level 5
Level 6
Mechanism of action
Search
Mechanism of action
BLAST against human drug target
BLAST against selected species (UniProt)
Exposure
Browse
Monitoring data
Downloads
Web services
Bulk downloads
About
About EcoDrug+
Citing
Data Sources
FAQ
Contact Us
Versions
Display Options:
Molecule Type
Mechanism of Action
Route of Adminstration
Status
Therapeutic Indication
Number of compounds:
7959
BIMOSIAMOSE
(2)
Small molecule
Selectin inhibitor
Unknown
Investigational
Unknown
BIMOSIAMOSE
×
Maximum Phase:
2
First Approval:
None
UNII:
97B5KCW80W
Molecule Type:
Small molecule
Molecular Formula:
C46H54O16
Molecular Weight:
862.92
AlogP:
1.98
PSA:
273.36
HBD:
10.0
HBA:
#RotB:
19.0
Source:
POSELTINIB
(2)
Small molecule
Tyrosine-protein kinase BTK inhibitor
Unknown
Investigational
Unknown
POSELTINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
D01E4B1U35
Molecule Type:
Small molecule
Molecular Formula:
C26H26N6O3
Molecular Weight:
470.53
AlogP:
4.64
PSA:
95.76
HBD:
2.0
HBA:
#RotB:
7.0
Source:
LY-2880070
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
LY-2880070
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
PSI-352938
(2)
Small molecule
Hepatitis C virus NS5B RNA-dependent RNA polymerase inhibitor
Unknown
Investigational
Unknown
PSI-352938
×
Maximum Phase:
2
First Approval:
None
UNII:
3Z30JH9QX1
Molecule Type:
Small molecule
Molecular Formula:
C16H23FN5O6P
Molecular Weight:
431.36
AlogP:
2.38
PSA:
132.84
HBD:
1.0
HBA:
#RotB:
5.0
Source:
METHOXYAMINE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
METHOXYAMINE
×
Maximum Phase:
2
First Approval:
None
UNII:
9TZH4WY30J
Molecule Type:
Small molecule
Molecular Formula:
CH5NO
Molecular Weight:
47.06
AlogP:
-0.49
PSA:
35.25
HBD:
1.0
HBA:
#RotB:
0.0
Source:
CARMEGLIPTIN
(2)
Small molecule
Dipeptidyl peptidase IV inhibitor
Unknown
Investigational
Unknown
CARMEGLIPTIN
×
Maximum Phase:
2
First Approval:
None
UNII:
9Z723VGH7J
Molecule Type:
Small molecule
Molecular Formula:
C20H28FN3O3
Molecular Weight:
377.46
AlogP:
1.52
PSA:
68.03
HBD:
1.0
HBA:
#RotB:
4.0
Source:
UDIFITIMOD
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
UDIFITIMOD
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
LY-2608204
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
LY-2608204
×
Maximum Phase:
2
First Approval:
None
UNII:
5A0L003HEY
Molecule Type:
Small molecule
Molecular Formula:
C28H37N3O3S3
Molecular Weight:
559.82
AlogP:
5.74
PSA:
79.37
HBD:
1.0
HBA:
#RotB:
10.0
Source:
ELZASONAN HYDROCHLORIDE
(2)
Small molecule
Serotonin 1b (5-HT1b) receptor antagonist
Unknown
Investigational
Unknown
ELZASONAN HYDROCHLORIDE
×
Maximum Phase:
2
First Approval:
None
UNII:
X38F62RR8L
Molecule Type:
Small molecule
Molecular Formula:
C22H24Cl3N3OS
Molecular Weight:
484.88
AlogP:
4.87
PSA:
26.79
HBD:
0.0
HBA:
#RotB:
3.0
Source:
PF-00610355
(2)
Small molecule
Beta-2 adrenergic receptor agonist
Unknown
Investigational
Unknown
PF-00610355
×
Maximum Phase:
2
First Approval:
None
UNII:
ZH5SMU97AJ
Molecule Type:
Small molecule
Molecular Formula:
C34H39N3O6S
Molecular Weight:
617.77
AlogP:
4.64
PSA:
147.99
HBD:
6.0
HBA:
#RotB:
13.0
Source:
DIFLOMOTECAN
(2)
Small molecule
DNA topoisomerase I inhibitor
Unknown
Investigational
Unknown
DIFLOMOTECAN
×
Maximum Phase:
2
First Approval:
None
UNII:
QKT1LC4J1P
Molecule Type:
Small molecule
Molecular Formula:
C21H16F2N2O4
Molecular Weight:
398.37
AlogP:
2.75
PSA:
81.42
HBD:
1.0
HBA:
#RotB:
1.0
Source:
BMS-955176
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
BMS-955176
×
Maximum Phase:
2
First Approval:
None
UNII:
4CA9IAU7RJ
Molecule Type:
Small molecule
Molecular Formula:
C42H62N2O4S
Molecular Weight:
691.03
AlogP:
8.11
PSA:
86.71
HBD:
2.0
HBA:
#RotB:
7.0
Source:
MK-0736
(2)
Small molecule
11-beta-hydroxysteroid dehydrogenase 1 inhibitor
Unknown
Investigational
Unknown
MK-0736
×
Maximum Phase:
2
First Approval:
None
UNII:
9RT16RBU2Y
Molecule Type:
Small molecule
Molecular Formula:
C23H30F3N3O2S
Molecular Weight:
469.57
AlogP:
5.31
PSA:
64.85
HBD:
0.0
HBA:
#RotB:
7.0
Source:
METACAVIR
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
METACAVIR
×
Maximum Phase:
2
First Approval:
None
UNII:
W5EOS3V193
Molecule Type:
Small molecule
Molecular Formula:
C11H15N5O3
Molecular Weight:
265.27
AlogP:
0.09
PSA:
108.31
HBD:
2.0
HBA:
#RotB:
3.0
Source:
VALOMACICLOVIR STEARATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
VALOMACICLOVIR STEARATE
×
Maximum Phase:
2
First Approval:
None
UNII:
506LI1B3A3
Molecule Type:
Small molecule
Molecular Formula:
C33H58N6O5
Molecular Weight:
618.86
AlogP:
6.04
PSA:
168.21
HBD:
3.0
HBA:
#RotB:
25.0
Source:
PADOPORFIN
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
PADOPORFIN
×
Maximum Phase:
2
First Approval:
None
UNII:
OIH1H7CJCJ
Molecule Type:
Small molecule
Molecular Formula:
C36H40N4O5Pd
Molecular Weight:
715.16
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
DANIRIXIN
(2)
Small molecule
Interleukin-8 receptor B antagonist
Unknown
Investigational
Unknown
DANIRIXIN
×
Maximum Phase:
2
First Approval:
None
UNII:
R318PGH5VP
Molecule Type:
Small molecule
Molecular Formula:
C19H21ClFN3O4S
Molecular Weight:
441.91
AlogP:
3.66
PSA:
107.53
HBD:
4.0
HBA:
#RotB:
4.0
Source:
TOZASERTIB
(2)
Small molecule
Serine/threonine-protein kinase Aurora inhibitor
Unknown
Investigational
Unknown
TOZASERTIB
×
Maximum Phase:
2
First Approval:
None
UNII:
234335M86K
Molecule Type:
Small molecule
Molecular Formula:
C23H28N8OS
Molecular Weight:
464.6
AlogP:
3.5
PSA:
102.07
HBD:
3.0
HBA:
#RotB:
7.0
Source:
TRIMEBUTINE 3-THIOCARBAMOYLBENZENESULFONATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TRIMEBUTINE 3-THIOCARBAMOYLBENZENESULFONATE
×
Maximum Phase:
2
First Approval:
None
UNII:
5O1CF9IS48
Molecule Type:
Small molecule
Molecular Formula:
C29H36N2O8S2
Molecular Weight:
604.75
AlogP:
None
PSA:
None
HBD:
None
HBA:
#RotB:
None
Source:
ANTROQUINONOL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
ANTROQUINONOL
×
Maximum Phase:
2
First Approval:
None
UNII:
AX9P92T7JZ
Molecule Type:
Small molecule
Molecular Formula:
C24H38O4
Molecular Weight:
390.56
AlogP:
5.5
PSA:
55.76
HBD:
1.0
HBA:
#RotB:
10.0
Source:
TLC-388
(2)
Small molecule
DNA topoisomerase I inhibitor
Unknown
Investigational
Unknown
TLC-388
×
Maximum Phase:
2
First Approval:
None
UNII:
D47234N30N
Molecule Type:
Small molecule
Molecular Formula:
C39H30N8O15
Molecular Weight:
850.71
AlogP:
4.87
PSA:
305.11
HBD:
1.0
HBA:
#RotB:
11.0
Source:
PC-786
(2)
Small molecule
RNA-directed RNA polymerase L inhibitor
Unknown
Investigational
Unknown
PC-786
×
Maximum Phase:
2
First Approval:
None
UNII:
MC0MD9J0F4
Molecule Type:
Small molecule
Molecular Formula:
C41H38FN5O4S
Molecular Weight:
715.85
AlogP:
7.89
PSA:
103.87
HBD:
2.0
HBA:
#RotB:
6.0
Source:
E-FLUPENTIXOL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
E-FLUPENTIXOL
×
Maximum Phase:
2
First Approval:
None
UNII:
895OJP78MJ
Molecule Type:
Small molecule
Molecular Formula:
C23H25F3N2OS
Molecular Weight:
434.53
AlogP:
4.6
PSA:
26.71
HBD:
1.0
HBA:
#RotB:
5.0
Source:
HE3286
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
HE3286
×
Maximum Phase:
2
First Approval:
None
UNII:
PH8858757I
Molecule Type:
Small molecule
Molecular Formula:
C21H30O3
Molecular Weight:
330.47
AlogP:
2.65
PSA:
60.69
HBD:
3.0
HBA:
#RotB:
0.0
Source:
VX-135
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
VX-135
×
Maximum Phase:
2
First Approval:
None
UNII:
Molecule Type:
Small molecule
Molecular Formula:
Molecular Weight:
AlogP:
PSA:
HBD:
HBA:
#RotB:
Source:
DENAGLIPTIN TOSYLATE
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
DENAGLIPTIN TOSYLATE
×
Maximum Phase:
2
First Approval:
None
UNII:
T47477CUF7
Molecule Type:
Small molecule
Molecular Formula:
C27H26F3N3O4S
Molecular Weight:
545.58
AlogP:
2.89
PSA:
70.12
HBD:
1.0
HBA:
#RotB:
4.0
Source:
MITEMCINAL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
MITEMCINAL
×
Maximum Phase:
2
First Approval:
None
UNII:
6X5NRJ664L
Molecule Type:
Small molecule
Molecular Formula:
C40H69NO12
Molecular Weight:
755.99
AlogP:
4.53
PSA:
151.68
HBD:
2.0
HBA:
#RotB:
9.0
Source:
SELODENOSON
(2)
Small molecule
Adenosine A1 receptor agonist
Unknown
Investigational
Unknown
SELODENOSON
×
Maximum Phase:
2
First Approval:
None
UNII:
103G5E953K
Molecule Type:
Small molecule
Molecular Formula:
C17H24N6O4
Molecular Weight:
376.42
AlogP:
-0.06
PSA:
134.42
HBD:
4.0
HBA:
#RotB:
5.0
Source:
DIMEPHEPTANOL
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
DIMEPHEPTANOL
×
Maximum Phase:
2
First Approval:
None
UNII:
NNB4I01PA7
Molecule Type:
Small molecule
Molecular Formula:
C21H29NO
Molecular Weight:
311.47
AlogP:
4.08
PSA:
23.47
HBD:
1.0
HBA:
#RotB:
7.0
Source:
TELACEBEC
(2)
Small molecule
Unknown
Unknown
Investigational
Unknown
TELACEBEC
×
Maximum Phase:
2
First Approval:
None
UNII:
55G92WGH3X
Molecule Type:
Small molecule
Molecular Formula:
C29H28ClF3N4O2
Molecular Weight:
557.02
AlogP:
6.76
PSA:
58.87
HBD:
1.0
HBA:
#RotB:
7.0
Source:
2X-121
(2)
Small molecule
Poly [ADP-ribose] polymerase 2 inhibitor
Unknown
Investigational
Unknown
2X-121
×
Maximum Phase:
2
First Approval:
None
UNII:
9X5A2QIA7C
Molecule Type:
Small molecule
Molecular Formula:
C18H15N5O
Molecular Weight:
317.35
AlogP:
2.39
PSA:
73.38
HBD:
2.0
HBA:
#RotB:
2.0
Source:
AMUVATINIB
(2)
Small molecule
Hepatocyte growth factor receptor inhibitor
Unknown
Investigational
Unknown
AMUVATINIB
×
Maximum Phase:
2
First Approval:
None
UNII:
SO9S6QZB4R
Molecule Type:
Small molecule
Molecular Formula:
C23H21N5O3S
Molecular Weight:
447.52
AlogP:
3.3
PSA:
75.89
HBD:
1.0
HBA:
#RotB:
3.0
Source:
ANATIBANT
(2)
Small molecule
Bradykinin B2 receptor antagonist
Unknown
Investigational
Unknown
ANATIBANT
×
Maximum Phase:
2
First Approval:
None
UNII:
CLO4JRD21F
Molecule Type:
Small molecule
Molecular Formula:
C34H36Cl2N6O5S
Molecular Weight:
711.67
AlogP:
5.11
PSA:
167.57
HBD:
4.0
HBA:
#RotB:
12.0
Source:
LY-2940094
(2)
Small molecule
Nociceptin receptor antagonist
Unknown
Investigational
Unknown
LY-2940094
×
Maximum Phase:
2
First Approval:
None
UNII:
4I67US2V8Q
Molecule Type:
Small molecule
Molecular Formula:
C22H23ClF2N4O2S
Molecular Weight:
480.97
AlogP:
4.4
PSA:
63.41
HBD:
1.0
HBA:
#RotB:
4.0
Source:
TBA-7371
(2)
Small molecule
FAD-dependent decaprenylphosphoryl-beta-D-ribofuranose 2-oxidase inhibitor
Unknown
Investigational
Unknown
TBA-7371
×
Maximum Phase:
2
First Approval:
None
UNII:
R3T98GBE3C
Molecule Type:
Small molecule
Molecular Formula:
C18H21N5O3
Molecular Weight:
355.4
AlogP:
1.22
PSA:
102.16
HBD:
2.0
HBA:
#RotB:
6.0
Source:
BMS-777607
(2)
Small molecule
Hepatocyte growth factor receptor inhibitor
Unknown
Investigational
Unknown
BMS-777607
×
Maximum Phase:
2
First Approval:
None
UNII:
A3MMS6HDO1
Molecule Type:
Small molecule
Molecular Formula:
C25H19ClF2N4O4
Molecular Weight:
512.9
AlogP:
5.19
PSA:
108.47
HBD:
2.0
HBA:
#RotB:
7.0
Source:
1
2
…
133
134
135
136
137
138
139
…
221
222
Next »
Download Option
Header
Compound Name
Maximum Phase
Compound Structure
Smile
Inchi
InchiKey
Compound Properties
Molecular Formula
Molecular Weight
ALogP
PSA